Author
Listed:
- Sheikh Jarju
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Rhys D. Wenlock
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Madikoi Danso
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Dawda Jobe
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Ya Jankey Jagne
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Alansana Darboe
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Michelle Kumado
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Yusupha Jallow
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Mamlie Touray
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Ebrima A. Ceesay
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Hoja Gaye
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Biran Gaye
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Abdoulie Tunkara
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Sheriff Kandeh
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Marie Gomes
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Ellen Lena Sylva
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Fatoumata Toure
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Hailey Hornsby
(The University of Sheffield
The University of Sheffield)
- Benjamin B. Lindsey
(The University of Sheffield
The University of Sheffield)
- Martin J. Nicklin
(The University of Sheffield
The University of Sheffield)
- Jon R. Sayers
(The University of Sheffield
The University of Sheffield)
- Abdul K. Sesay
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine)
- Adam Kucharski
(London School of Hygiene and Tropical Medicine)
- David Hodgson
(London School of Hygiene and Tropical Medicine)
- Beate Kampmann
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine
Charité Universitätsmedizin)
- Thushan I. Silva
(Medical Research Council The Gambia at the London School of Hygiene and Tropical Medicine
The University of Sheffield
The University of Sheffield)
Abstract
Little is known about SARS-CoV-2 infection risk in African countries with high levels of infection-driven immunity and low vaccine coverage. We conducted a prospective cohort study of 349 participants from 52 households in The Gambia between March 2021 and June 2022, with routine weekly SARS-CoV-2 RT-PCR and 6-monthly SARS-CoV-2 serology. Attack rates of 45% and 57% were seen during Delta and Omicron BA.1 waves respectively. Eighty-four percent of RT-PCR-positive infections were asymptomatic. Children under 5-years had a lower incidence of infection than 18-49-year-olds. One prior SARS-CoV-2 infection reduced infection risk during the Delta wave only, with immunity from ≥2 prior infections required to reduce the risk of infection with early Omicron lineage viruses. In an African population with high levels of infection-driven immunity and low vaccine coverage, we find high attack rates during SARS-CoV-2 waves, with a high proportion of asymptomatic infections and young children remaining relatively protected from infection.
Suggested Citation
Sheikh Jarju & Rhys D. Wenlock & Madikoi Danso & Dawda Jobe & Ya Jankey Jagne & Alansana Darboe & Michelle Kumado & Yusupha Jallow & Mamlie Touray & Ebrima A. Ceesay & Hoja Gaye & Biran Gaye & Abdouli, 2024.
"High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia,"
Nature Communications, Nature, vol. 15(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48098-3
DOI: 10.1038/s41467-024-48098-3
Download full text from publisher
References listed on IDEAS
- Kaiyuan Sun & Stefano Tempia & Jackie Kleynhans & Anne Gottberg & Meredith L. McMorrow & Nicole Wolter & Jinal N. Bhiman & Jocelyn Moyes & Maimuna Carrim & Neil A. Martinson & Kathleen Kahn & Limakats, 2023.
"Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa,"
Nature Communications, Nature, vol. 14(1), pages 1-13, December.
- Danillo G. Augusto & Lawton D. Murdolo & Demetra S. M. Chatzileontiadou & Joseph J. Sabatino & Tasneem Yusufali & Noah D. Peyser & Xochitl Butcher & Kerry Kizer & Karoline Guthrie & Victoria W. Murray, 2023.
"A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection,"
Nature, Nature, vol. 620(7972), pages 128-136, August.
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Joseph A. Lewnard & Vennis Hong & Jeniffer S. Kim & Sally F. Shaw & Bruno Lewin & Harpreet Takhar & Sara Y. Tartof, 2023.
"Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome,"
Nature Communications, Nature, vol. 14(1), pages 1-11, December.
- Asolina Braun & Louise C. Rowntree & Ziyi Huang & Kirti Pandey & Nikolas Thuesen & Chen Li & Jan Petersen & Dene R. Littler & Shabana Raji & Thi H. O. Nguyen & Emma Jappe Lange & Gry Persson & Michael, 2024.
"Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes,"
Nature Communications, Nature, vol. 15(1), pages 1-12, December.
- Rúbens Prince dos Santos Alves & Julia Timis & Robyn Miller & Kristen Valentine & Paolla Beatriz Almeida Pinto & Andrew Gonzalez & Jose Angel Regla-Nava & Erin Maule & Michael N. Nguyen & Norazizah Sh, 2024.
"Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice,"
Nature Communications, Nature, vol. 15(1), pages 1-20, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48098-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.